HEALTHPEAK PROPERTIES, INC.
DOCAPI behind this page
DOC Q3 2025 request
Playground key active
/api/financials?ticker=DOC&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Operating Lease Lease Income | 539,886 | 543,251 | -0.6% |
| Revenue | 150,458 | 142,845 | +5.3% |
| Interest Income Operating | 15,529 | 14,301 | +8.6% |
| Revenue | 705,873 | 700,397 | +0.8% |
Show Business Segments breakouts |
|||
| CCRC · Operating Segments | 150,458 | 142,845 | +5.3% |
| Lab Buildings · Operating Segments | 213,325 | 225,592 | -5.4% |
| Outpatient Medical Buildings · Operating Segments | 326,561 | 317,659 | +2.8% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 690,344 | 686,096 | +0.6% |
| Interest Expense | 76,784 | 74,105 | +3.6% |
| Depreciation And Amortization | 262,317 | 280,019 | -6.3% |
| Cost of Revenue | 291,922 | 280,279 | +4.2% |
| General & Administrative | 19,907 | 23,216 | -14.3% |
| Business Combination Acquisition Related Costs | 2,420 | 7,134 | -66.1% |
Show Business Acquisition breakouts |
|||
| Physicians Realty Trust | 2 | 6 | -66.7% |
| Impairments And Allowance For Credit Loss Reserves Recoveries Net | -54 | 441 | -112.2% |
| Total Costs & Expenses | 653,296 | 665,194 | -1.8% |
| Gains Losses On Sales Of Investment Real Estate | 11,500 | 62,325 | -81.5% |
Show Business Segments breakouts |
|||
| Outpatient Medical Buildings | 12 | 60 | -80.0% |
| Other Non-Operating Income (Expense) | 1,160 | 982 | +18.1% |
| Non-Operating Income (Expense) | 12,660 | 63,307 | -80.0% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 65,237 | 98,510 | -33.8% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 65,237 | 98,510 | -33.8% |
| Income Tax Expense (Benefit) | 1,206 | -1,938 | +162.2% |
| Income Loss From Equity Method Investments | -176,291 | -3,834 | -4498.1% |
| Net Income | -109,848 | 92,738 | -218.4% |
| Income Loss From Continuing Operations Attributable To Noncontrolling Entity | -7,274 | -6,866 | -5.9% |
| Net Income | -117,122 | 85,872 | -236.4% |
| Participating Securities Distributed And Undistributed Earnings Loss Basic | -134 | -197 | +32.0% |
| Net Income Loss Available To Common Stockholders Basic | -117,256 | 85,675 | -236.9% |
| EPS (Basic) | -0.17 | 0.12 | -241.7% |
| EPS (Diluted) | -0.17 | 0.12 | -241.7% |
| Wtd Avg Shares (Basic) | 694,930 | 699,349 | -0.6% |
| Wtd Avg Shares (Diluted) | 694,930 | 700,146 | -0.7% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| CCRC · Operating Segments | 113,910 | 109,720 | +3.8% |
| Lab Buildings · Operating Segments | 64,352 | 64,075 | +0.4% |
| Lab · Operating Segments | 64,352 | 64,075 | +0.4% |
| Outpatient Medical Buildings · Operating Segments | 113,660 | 106,484 | +6.7% |
| Outpatient medical · Operating Segments | 113,660 | 106,484 | +6.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 291,922 | 280,279 | +4.2% |
| Comprehensive Income | -120,078 | 31,194 | -484.9% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | -3,027 | -54,742 | +94.5% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 91,038 | 180,430 | -49.5% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 43,806 | 29,821 | +46.9% |
| Non-Current Assets | |||
| Operating Lease Right-of-Use Assets | 417,365 | 427,711 | -2.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 269,797 | 273,512 | -1.4% |
| Variable Interest Entity Primary Beneficiary · Discontinued Operations Heldforsale | 7 | — | — |
| Total Assets | 19,582,401 | 19,969,766 | -1.9% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 6,058,257 | 6,240,097 | -2.9% |
| Goodwill | 68,529 | — | — |
Show Business Segments breakouts |
|||
| CCRC | 1,998 | — | — |
| Other non-reportable | 1,851 | — | — |
| Outpatient medical | 64,680 | — | — |
| Intangible Assets | 610,513 | 898,379 | -32.0% |
| Other Assets | |||
| Investment Building And Building Improvements | 16,192,972 | 16,059,802 | +0.8% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 4,707,134 | 4,644,946 | +1.3% |
| Real Estate Investment Property Accumulated Depreciation | -4,438,273 | -3,925,375 | -13.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | -895,705 | -708,261 | -26.5% |
| Real Estate Investment Property Net | 15,831,173 | 15,892,412 | -0.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 4,420,563 | 4,518,766 | -2.2% |
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss | 673,502 | 677,590 | -0.6% |
Show Business Segments breakouts |
|||
| Other non-reportable · Brookedale MTCA | 67 | 56 | +19.6% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 566,552 | 518,292 | +9.3% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 796,171 | 931,844 | -14.6% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 25,481 | 43,362 | -41.2% |
| Accounts Receivable Net | 80,845 | 64,979 | +24.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 23,273 | 13,312 | +74.8% |
| Restricted Cash And Cash Equivalents | 68,694 | 61,615 | +11.5% |
| Intangible Assets Net Excluding Goodwill | 610,513 | 898,379 | -32.0% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 490,005 | 689,869 | -29.0% |
| Assets Held For Sale Not Part Of Disposal Group | 67,593 | — | — |
Show Disposal Group Classification breakouts |
|||
| Discontinued Operations Heldforsale | 68 | — | — |
| Other Assets | 945,507 | 834,806 | +13.3% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 180,651 | 151,108 | +19.6% |
| Non-Current Liabilities | |||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | 746,229 | 749,881 | -0.5% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 142,859 | 144,662 | -1.2% |
| Total Liabilities | 11,317,097 | 10,747,763 | +5.3% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 2,302,802 | 2,314,447 | -0.5% |
| Long-Term Debt | 9,131,561 | 8,583,377 | +6.4% |
Show Long-Term Debt Type breakouts |
|||
| Commercial Paper | 368,125 | — | — |
| Loans Payable | 1,646,912 | 1,645,748 | +0.1% |
| Secured Debt | 350,174 | 380,459 | -8.0% |
| Unsecured Debt | 6,766,350 | 6,557,170 | +3.2% |
| Other Liabilities | |||
| Bank Line Of Credit And Commercial Paper | 368,125 | — | — |
| Loans Payable To Bank | 1,646,912 | 1,645,748 | +0.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 401,502 | 402,025 | -0.1% |
| Unsecured Debt | 6,766,350 | 6,557,170 | +3.2% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Estimate Of Fair Value Fair Value Disclosure | 6,781,049 | 6,295,839 | +7.7% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 1,164,248 | 1,147,761 | +1.4% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 6,766,350 | 6,557,170 | +3.2% |
| Secured Debt | 350,174 | 380,459 | -8.0% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure | 348,418 | 378,038 | -7.8% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 245,691 | 270,467 | -9.2% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 350,174 | 380,459 | -8.0% |
| Off Market Lease Unfavorable | 155,557 | 202,857 | -23.3% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 80,210 | 100,781 | -20.4% |
| Liabilities Related To Assets Held For Sale Net | 12,371 | — | — |
| Operating Lease Liability | 301,302 | 308,277 | -2.3% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 195,277 | 193,422 | +1.0% |
| Variable Interest Entity Primary Beneficiary · Discontinued Operations Heldforsale | 9 | — | — |
| Contract With Customer Liability | 970,077 | 903,371 | +7.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 61,217 | 55,329 | +10.6% |
| Variable Interest Entity Primary Beneficiary · Discontinued Operations Heldforsale | 3 | — | — |
| Redeemable Noncontrolling Interest Equity Carrying Amount | 27,809 | 1,318 | +2009.9% |
| Accumulated Distributions In Excess Of Net Income | -5,854,766 | -4,968,819 | -17.8% |
| Minority Interest In Joint Ventures | 296,477 | 321,949 | -7.9% |
| Minority Interest In Preferred Unit Holders | 343,743 | 335,897 | +2.3% |
Show Other Ownership Interests By Name breakouts |
|||
| Down REIT | 307 | — | — |
| Minority Interest | 640,220 | 657,846 | -2.7% |
| Stockholders' Equity | |||
| Common Stock | 694,946 | 699,405 | -0.6% |
| Additional Paid-In Capital | 12,765,070 | 12,844,634 | -0.6% |
| Accumulated Other Comprehensive Income | -7,975 | -12,381 | +35.6% |
| Total Stockholders' Equity | 7,597,275 | 8,562,839 | -11.3% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 8,237,495 | 9,220,685 | -10.7% |
Show Equity Components breakouts |
|||
| Accumulated Distributions In Excess Of Net Income | -5,854,766 | -4,968,819 | -17.8% |
| Accumulated Other Comprehensive Income | -7,975 | -12,381 | +35.6% |
| Additional Paid In Capital | 12,765,070 | 12,844,634 | -0.6% |
| Common Stock | 694,946 | 699,405 | -0.6% |
| Noncontrolling Interest | 640,220 | 657,846 | -2.7% |
| Parent | 7,597,275 | 8,562,839 | -11.3% |
| Total Liabilities & Equity | 19,582,401 | 19,969,766 | -1.9% |
| Development In Process | 1,148,903 | 830,310 | +38.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 135,076 | 107,216 | +26.0% |
| Land And Land Improvements | 2,927,571 | 2,927,675 | -0.0% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 474,058 | 474,865 | -0.2% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Other Depreciation And Amortization | 796,779 | 782,736 | +1.8% |
| Stock-Based Compensation | 10,410 | 11,935 | -12.8% |
| Amortization Of Financing Costs And Discounts | 23,708 | 19,247 | +23.2% |
| Straight Line Rent | -30,836 | -32,891 | +6.2% |
| Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net | -100,215 | -88,925 | -12.7% |
| Income Loss From Equity Method Investments Including Discontinued Operations | 176,691 | 1,407 | +12458.0% |
| Equity Method Investment Dividends Or Distributions | 16,861 | 11,228 | +50.2% |
| Deferred Income Taxes And Tax Credits | -131 | 11,156 | -101.2% |
| Asset Impairment Charges | -117 | 11,346 | -101.0% |
| Gain Loss On Sale Of Investments | -13,136 | -187,624 | +93.0% |
| Insured Event Gain Loss | 9,825 | -574 | +1811.7% |
| Other Non-Cash Items | -7,826 | -1,652 | -373.7% |
| Increase Decrease In Accounts Receivable And Other Operating Assets | 9,756 | 2,071 | +371.1% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 86,871 | 52,200 | +66.4% |
| Net Cash from Operations | 957,875 | 786,966 | +21.7% |
| Investing Activities | |||
| Payments To Acquire Other Real Estate | -43,880 | -4,466 | -882.5% |
| Payments To Develop Real Estate Assets | -547,087 | -399,373 | -37.0% |
| Payments For Leasing Costs Commissions And Tenant Improvements | -76,125 | -76,744 | +0.8% |
| Proceeds From Sale Of Real Estate Heldforinvestment | 30,839 | 619,981 | -95.0% |
| Payments To Acquire Interest In Subsidiaries And Affiliates | -76,329 | -54,450 | -40.2% |
| Distributions In Excess Of Earnings From Unconsolidated Joint Ventures | 22,745 | 20,195 | +12.6% |
| Proceeds From Insurance Settlement Investing Activities | 12,214 | 6,467 | +88.9% |
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | 125,927 | 87,259 | +44.3% |
| Payments To Acquire Loans Receivable And Other | -77,357 | -25,341 | -205.3% |
| Net Cash from Investing | -629,053 | 119,975 | -624.3% |
| Financing Activities | |||
| Proceeds From Lines Of Credit | 9,435,650 | 3,146,250 | +199.9% |
| Repayments Of Lines Of Credit | -9,217,525 | -3,866,250 | -138.4% |
| Proceeds From Bank Debt | 987,260 | 750,000 | +31.6% |
| Repayments Of Bank Debt | -806,492 | -3,038 | -26446.8% |
| Payments Of Debt Extinguishment Costs | -2,604 | -5,438 | +52.1% |
| Proceeds From Issuance Or Sale Of Equity | 304 | 241 | +26.1% |
| Share Repurchases | -97,058 | -190,364 | +49.0% |
| Payments Of Dividends | -637,234 | -584,964 | -8.9% |
| Payments To Minority Shareholders | -28,820 | -80,368 | +64.1% |
| Proceeds From Minority Shareholders | 13,124 | 12 | +109266.7% |
| Net Cash from Financing | -353,395 | -833,919 | +57.6% |
| Amortization of Financing Costs (YTD) | — | — | — |
Show Short Term Debt Type breakouts |
|||
| Commercial Paper Program | 7 | 7 | 0.0% |
| Supplemental | |||
| Income Taxes Paid | 2,089 | 6,820 | -69.4% |
| Interest Paid | 219,686 | 204,858 | +7.2% |
| Other Cash Flow | |||
| Net Change in Cash | -24,573 | 73,022 | -133.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 159,732 | 242,045 | -34.0% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.